Brain Cancer Caused by Zantac, Ranitidine, Valsartan and Metformin
Drug Liability Attorneys in New York for Brain Cancer and Brain Tumors - Call (888) 260-0473
Have you used recalled Zantac, Ranitidine, Valsartan or Metformin and recently been diagnosed with a brain cancer or tumor? You can contact our firm and ask questions about this very new medical development and learn about your potential rights. The online Valisure Pharmacy, with Stanford University, published a major report on the cancers associated with Zantac and oncologist Dr. Lior Braunstein studies Zantac use and cancer at Memorial Sloan Kettering.
The leading cause of the recall was the carcinogen N-Nitrosodimethylamine (NDMA) being found within the drugs, or created by digestive actions. NDMA is a known carcinogen which has strict limits for daily intake. NDMA is “genotoxic,” meaning that enters cellular DNA and can cause immediate cancerous growth. At Rheingold Giuffra Ruffo & Plotkin LLP, our New York defective drug lawyers handle cases directly and do not refer them to other firms.
ZANTAC, Ranitidine, Valsartan, AND Metformin MAKERS HALT SHIPPING ON NDMA CARCINOGEN CONCERN
New York City Attorneys Speaking with Zantac, Ranitidine, Valsartan, Metformin Users & Filing Cancer Lawsuits
Have you been diagnosed with cancer after prolonged use to these drugs? Recent studies suggest there is a positive correlation between NDMA use and the formation of carcinogens, including brain tumors. You may be able to file a cancer lawsuit if you developed cancer while consuming these drugs for a prolonged period of time. Use the contact form on this page for a free case evaluation by one of our experienced dangerous drug attorneys. You may also call our office directly at (888) 260-0473 to discuss your drug cancer lawsuit and possible settlement. At Rheingold Giuffra Ruffo & Plotkin LLP, our New York defective drug lawyers handle cases directly and do not refer them to other firms.
N-NITROSODIMETHYLAMINE (NDMA) CROSSES THE BLOOD/BRAIN BARRIER RAISING CARCINOGEN CONCERN
Repeated medical studies have shown that N-nitroso compounds have been clearly identified as carcinogens which can cause central nervous system and brain tumors. NDMA is a small particle and passes through the blood/brain barrier. Scientific investigations reveal that endothelial cells of the blood/brain barrier are large enough to let the small NDMA molecules pass through and expose the brain to DNA damage by N-nitroso compounds which are found in Zantac, Ranitidine, Valsartan or Metformin.[i]
Common brain cancers may include:
- Acoustic Neuroma
- CNS Lymphoma
- Other Gliomas:
- Metastatic Brain Tumors
- Pituitary Tumors
- Primitive Neuroectodermal (PNET)
- Other Brain-Related Conditions
The exact causes are known, but some forms have been related to chemical and industrial exposure. The chemicals in industrial exposure can be similar to N-Nitrosodimethylamine (NDMA), which was invented as rocket fuel.[ii]
Our New York dangerous drug lawyers perform a rigorous investigation of the impact this injury has had on clients and their families, both medically and financially. We have access to expert witnesses in pharmacology and other relevant fields who help us determine how dangerous drugs contributed to your injuries and who is liable for the damages. We offer every client personal, individual and attentive client service and dedication to results. Furthermore, through our extensive litigation against pharmaceutical companies, we are experienced with lawsuits involving dangerous drugs, and foreign pharmaceutical.
Our New York defective drug attorneys are able to handle a wide range of drug liability claims, including those involving these medications. Call (888) 260-0473 for a free case evaluation.
[i] J Anal Toxicol. 1987 Jan-Feb;11(1):12-8. Identification and quantitation of N-nitrosamines in human postmortem organs. Cooper SF, Lemoyne C, Gauvreau D. https://www.ncbi.nlm.nih.gov/pubmed/3821072;
J Alzheimers Dis. 2009; 17(4): 817–825. Mechanisms Of Nitrosamine–Mediated Neurodegeneration: Potential Relevance To Sporadic Alzheimer’s Disease; Suzanne M. de la Monte, M.D., M.P.H. and Ming Tong, M.D. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550318/;
Epidemiology of Brain Tumors; January 2005; Randa El-Zein file:///C:/Users/David/Desktop/zantac/Levin_ch10_p252-266.pdf
Auto Accident $2,750,000
Biopsy Resulting In Blindness $2,500,000
Birth Injury $1,000,000
Brain Damage $12,000,000
Brain Damage of Infant $1,000,000
Brain Damage of Infant $2,100,000
Cancer Misdiagnosis $2,500,000
Cardiovascular Injury $2,200,000
Cataract Surgery Complication $1,700,000
Child's Hand Injury $9,000,000